Cash, Cash Equivalents and Marketable Investments (Tables)

3 Months Ended

Mar. 31, 2023

Cash and Cash Equivalents [Abstract]

Schedule of Cash and Cash Equivalents

The following table summarizes the Company's cash and cash equivalents and marketable investments (in thousands):

			Gross		Gross		Fair
	Amortized		Unrealized		Unrealized		Market
March 31, 2023	Cost		Gains		Losses		Value
Cash and cash equivalents	N/A		N/A		N/A		$	166,828
Current restricted cash	N/A		N/A		N/A		700
Cash, cash equivalents, and restricted cash as reported within the Condensed Consolidated Statements of Cash Flows	N/A		N/A		N/A		167,528
Marketable investments - U.S. Treasury	100,831		133		(141)		100,823
Total	$	100,831	$	133	$	(141)	$	268,351

			Gross		Gross		Fair
	Amortized		Unrealized		Unrealized		Market
December 31, 2022	Cost		Gains		Losses		Value
Cash and cash equivalents	N/A		N/A		N/A		$	145,924
Current restricted cash	N/A		N/A		N/A		700
Cash, cash equivalents, and restricted cash as reported within the Condensed Consolidated Statements of Cash Flows	N/A		N/A		N/A		146,624
Marketable investments - U.S. Treasury	171,484		8		(102)		171,390
Total	$	171,484	$	8	$	(102)	$	318,014

Schedule of Restricted Cash and Cash Equivalents

The following table summarizes the Company's cash and cash equivalents and marketable investments (in thousands):

			Gross		Gross		Fair
	Amortized		Unrealized		Unrealized		Market
March 31, 2023	Cost		Gains		Losses		Value
Cash and cash equivalents	N/A		N/A		N/A		$	166,828
Current restricted cash	N/A		N/A		N/A		700
Cash, cash equivalents, and restricted cash as reported within the Condensed Consolidated Statements of Cash Flows	N/A		N/A		N/A		167,528
Marketable investments - U.S. Treasury	100,831		133		(141)		100,823
Total	$	100,831	$	133	$	(141)	$	268,351

			Gross		Gross		Fair
	Amortized		Unrealized		Unrealized		Market
December 31, 2022	Cost		Gains		Losses		Value
Cash and cash equivalents	N/A		N/A		N/A		$	145,924
Current restricted cash	N/A		N/A		N/A		700
Cash, cash equivalents, and restricted cash as reported within the Condensed Consolidated Statements of Cash Flows	N/A		N/A		N/A		146,624
Marketable investments - U.S. Treasury	171,484		8		(102)		171,390
Total	$	171,484	$	8	$	(102)	$	318,014

Schedule of Available-for-Sale Securities

The following table summarizes the Company's cash and cash equivalents and marketable investments (in thousands):

			Gross		Gross		Fair
	Amortized		Unrealized		Unrealized		Market
March 31, 2023	Cost		Gains		Losses		Value
Cash and cash equivalents	N/A		N/A		N/A		$	166,828
Current restricted cash	N/A		N/A		N/A		700
Cash, cash equivalents, and restricted cash as reported within the Condensed Consolidated Statements of Cash Flows	N/A		N/A		N/A		167,528
Marketable investments - U.S. Treasury	100,831		133		(141)		100,823
Total	$	100,831	$	133	$	(141)	$	268,351

			Gross		Gross		Fair
	Amortized		Unrealized		Unrealized		Market
December 31, 2022	Cost		Gains		Losses		Value
Cash and cash equivalents	N/A		N/A		N/A		$	145,924
Current restricted cash	N/A		N/A		N/A		700
Cash, cash equivalents, and restricted cash as reported within the Condensed Consolidated Statements of Cash Flows	N/A		N/A		N/A		146,624
Marketable investments - U.S. Treasury	171,484		8		(102)		171,390
Total	$	171,484	$	8	$	(102)	$	318,014